Investment
Features
FeesSafety
Academy
More
Pluang+

Appili Therapeutics to delist from TSX and move to TSX Venture Exchange NEX due to listing requirement issues.

Company Fundamentals
29 Sep 2026
Newsfile Corp
View Source
Neutral
Appili Therapeutics to delist from TSX and move to TSX Venture Exchange NEX due to listing requirement issues.

Appili Therapeutics announced it will voluntarily delist its Class A common shares from the Toronto Stock Exchange (TSX) on October 2, 2026, due to failure to meet TSX's continued listing requirements. The shares will begin trading on the TSX Venture Exchange NEX Board on October 5, 2026, with a new trading symbol "APLI.H". No shareholder approval is needed, and there will be no changes to the company's name or capital structure. This move reflects Appili's current challenges but allows continued trading on a different exchange.

Appili Therapeutics' transfer to the NEX board is noted here alongside Pluang's health sector data. For readers following health stocks, here is Pluang's market snapshot as of Sep 29, 2026 19:14 WIB: out of 100 priced US health-sector stocks, 50 rose and 41 fell. Notable movers include AbCellera Biologics Inc (ABCL) at USD 14.28 with a 1-day change of +2.59% and a typical hold time of 41 days, Amphastar Pharmaceuticals Inc (AMPH) at USD 28.08 with a 1-day change of +2.52% and a typical hold time of 16 days, and Axogen Inc (AXGN) at USD 42.37 with a 1-day change of -2.28% and a typical hold time of 19 days.

More News

Carlin Gold raises C$9.8M in private placement to fund Nevada exploration and appoints new director.

Carlin Gold raises C$9.8M in private placement to fund Nevada exploration and appoints new director.

Carlin Gold Corporation closed a brokered private placement, raising approximately C$9.8 million by selling 7.5 million units at C$1.30 each. Each unit includes one common share and a warrant exercisable at C$1.50 until 2028. The funds will support e...

Company Fundamentals
Bullish
4 hours ago
UBS maintains buy on RELX, sees AI fears as overblown with 42% upside potential.

UBS maintains buy on RELX, sees AI fears as overblown with 42% upside potential.

UBS reaffirmed its buy rating on RELX PLC with a 3,600p price target, arguing that concerns over AI and autonomous vehicles have led to an exaggerated drop in the stock price. The bank believes the impact of autonomous vehicles on RELX’s US auto insu...

Market News
Bullish
4 hours ago
Energy Transfer faces delays and market pressure but offers a timely buying opportunity amid challenges.

Energy Transfer faces delays and market pressure but offers a timely buying opportunity amid challenges.

Energy Transfer is experiencing significant delays and challenges with Project Jupiter, including permitting issues and a force majeure notification that have slowed execution. These setbacks, combined with rising long-term bond yields, have pressure...

Market News
Neutral
4 hours ago
Large-cap altcoins outperform Bitcoin in September with average gains of 39.1% vs Bitcoin's 7%.

Large-cap altcoins outperform Bitcoin in September with average gains of 39.1% vs Bitcoin's 7%.

In September, large-cap altcoins significantly outperformed Bitcoin, with 79 of 86 tokens gaining and 66 surpassing Bitcoin's 7% return. The average return for the altcoin sample was 39.1%, and the median gain was 27.5%, indicating widespread positiv...

Market News
Bullish
4 hours ago
City of Abbotsford issues soil permit for Affinor Growers' vertical farming site development

City of Abbotsford issues soil permit for Affinor Growers' vertical farming site development

Affinor Growers Inc. received a soil removal and deposit permit from the City of Abbotsford to prepare land for its vertical farming project at 34240 Page Road. The permit allows the company to deposit 2,780 cubic metres of soil to level the outdoor ...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App